Publications
5600 Results
- Journal / Conference
- Respiratory Research Mar 11;16(1):35
- Year
- 2015
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID25889509
- PMC
- PMC4404242
- Study Number(s)
- S0000C
A Randomized Controlled Trial of Vitamin E and Selenium on Rate of Decline in Lung Function
- Journal / Conference
- Journal of Pain and Symptom Management Oct;50(4):470-479
- Year
- 2015
- Research Committee(s)
- Lung and Symptom Management and Survivorship
- PMID
- PMID26031708
- PMC
- PMC4657556
- Study Number(s)
- S0027, S0509
The complimentary nature of patient reported outcomes (PROs) and adverse event reporting in cooperative group oncology clinical trials: a pooled analysis (NCCTG N0591/Alliance)
- Journal / Conference
- Journal of the National Cancer Institute Jun 25;107(9) pii: djv179. doi: 10.1093/jnci/djv179
- Year
- 2015
- Research Committee(s)
- Breast
- PMID
- PMID26113580
- PMC
- PMC4651106
- Study Number(s)
- C9741
Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer Patients Receiving Chemotherapy: Results from CALGB 9741 (ALLIANCE)
- Journal / Conference
- Cancer 121(3):432-440
- Year
- 2015
- Research Committee(s)
- Melanoma
- PMID
- PMID25250858
- PMC
- PMC4304973
- Study Number(s)
- S0933
A Phase II Study of RO4929097 Gamma-Secretase Inhibitor in Metastatic Melanoma: SWOG 0933
- Journal / Conference
- Journal of Thoracic Oncology 10(1):110-115
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID25490004
- PMC
- PMC4320001
- Study Number(s)
- S0327, S0435, S0802
Relevance of platinum sensitivity status in relapsed/refractory extensive stage small cell lung cancer (ES-SCLC) in the modern era: a patient level analysis of SWOG trials
- Journal / Conference
- Journal of Clinical Oncology May 1;33(13):1482-1490
- Year
- 2015
- Research Committee(s)
- Lymphoma
- PMID
- PMID25823738
- PMC
- PMC4404425
- Study Number(s)
- S0016, SWOG-8947, S9800, S9911
Low serum vitamin D levels are associated with inferior survival in follicular lymphoma: a prospective evaluation in SWOG and LYSA studies
- Journal / Conference
- PLOS ONE 10(3):e0117574
- Year
- 2015
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID25799011
- PMC
- PMC4370655
- Study Number(s)
- S0000
Vitamin D metabolic pathway genes and pancreatic cancer risk
- Journal / Conference
- Journal of Clinical Oncology 33(1):13-21
- Year
- 2015
- Research Committee(s)
- Breast
- PMID
- PMID25092775
- PMC
- PMC4268249
- Study Number(s)
- CTSU/C40603
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant weekly paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II-III triple-negative breast cancer: CALGB 40603 (Alliance)
- Journal / Conference
- Cancer Causes and Control 26(1):35-44
- Year
- 2015
- Research Committee(s)
- Cancer Control
- PMID
- PMID25359302
- PMC
- PMC4282945
- Study Number(s)
- SWOG-9217
Prospective study of human herpes virus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial
- Journal / Conference
- Clinical Lung Cancer Sep;16(5):340-347
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID25703100
- PMC
- PMC4497941
- Study Number(s)
- S0533